Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644)

MLA

Jean Emmanuel Kurtz, et al. “Quality of Life in Patients with Advanced High-Grade Ovarian Cancer (HGOC) Receiving Maintenance Therapies after First-Line (1L) Chemotherapy in the Randomized Phase III PAOLA-1/ENGOT-Ov25 Trial (NCT02477644).” Journal of Clinical Oncology, vol. 40, June 2022, p. 5560. EBSCOhost, https://doi.org/10.1200/jco.2022.40.16_suppl.5560.

APA

Jean Emmanuel Kurtz, Amélie Anota, Claire Cropet, Frank Priou, Philipp Harter, Sandro Pignata, Isabel Palacio, Edgar Petru, Hiroaki Kobayashi, Peter Vuylsteke, Gabriella Parma, Johanna Mäenpää, Eric Raymond, Paul Buderath, Domenica Lorusso, Ana Herrero, Nadia Raban, Eric Pujade-Lauraine, Florence Joly, & Isabelle Laure Ray-Coquard. (2022). Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644). Journal of Clinical Oncology, 40, 5560. https://doi.org/10.1200/jco.2022.40.16_suppl.5560

Chicago

Jean Emmanuel Kurtz, Amélie Anota, Claire Cropet, Frank Priou, Philipp Harter, Sandro Pignata, Isabel Palacio, et al. 2022. “Quality of Life in Patients with Advanced High-Grade Ovarian Cancer (HGOC) Receiving Maintenance Therapies after First-Line (1L) Chemotherapy in the Randomized Phase III PAOLA-1/ENGOT-Ov25 Trial (NCT02477644).” Journal of Clinical Oncology 40 (June): 5560. doi:10.1200/jco.2022.40.16_suppl.5560.